BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 37530731)

  • 1. Evaluation and management of exocrine pancreatic insufficiency: pearls and pitfalls.
    Ramsey ML; Hart PA; Forsmark CE
    Curr Opin Gastroenterol; 2023 Sep; 39(5):428-435. PubMed ID: 37530731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staging exocrine pancreatic dysfunction.
    Khan A; Vege SS; Dudeja V; Chari ST
    Pancreatology; 2022 Jan; 22(1):168-172. PubMed ID: 34916141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which factors determine exocrine pancreatic dysfunction in diabetes mellitus?
    Altay M
    World J Gastroenterol; 2019 Jun; 25(22):2699-2705. PubMed ID: 31235993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exocrine pancreatic insufficiency following esophagectomy.
    Huddy JR; Macharg FM; Lawn AM; Preston SR
    Dis Esophagus; 2013 Aug; 26(6):594-7. PubMed ID: 23199208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic Enzyme Replacement Therapy in Patients with Non-pancreatic Digestive Conditions: A Nationwide Claims Analysis.
    Phillips AE; Tang G; Wang X; Forsmark CE; Yadav D
    Dig Dis Sci; 2023 May; 68(5):1754-1761. PubMed ID: 36370243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of pancreatic enzyme replacement therapy to survival and quality of life in patients with pancreatic exocrine insufficiency.
    Layer P; Kashirskaya N; Gubergrits N
    World J Gastroenterol; 2019 May; 25(20):2430-2441. PubMed ID: 31171887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic Exocrine Insufficiency as a Complication of Gastrointestinal Surgery and the Impact of Pancreatic Enzyme Replacement Therapy.
    Chaudhary A; Domínguez-Muñoz JE; Layer P; Lerch MM
    Dig Dis; 2020; 38(1):53-68. PubMed ID: 31422398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and treatment of pancreatic exocrine insufficiency.
    Dominguez-Muñoz JE
    Curr Opin Gastroenterol; 2018 Sep; 34(5):349-354. PubMed ID: 29889111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of pancreatic exocrine insufficiency.
    Nikfarjam M; Wilson JS; Smith RC;
    Med J Aust; 2017 Aug; 207(4):161-165. PubMed ID: 28814218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer.
    Roeyen G; Berrevoet F; Borbath I; Geboes K; Peeters M; Topal B; Van Cutsem E; Van Laethem JL
    ESMO Open; 2022 Feb; 7(1):100386. PubMed ID: 35124465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Less common etiologies of exocrine pancreatic insufficiency.
    Singh VK; Haupt ME; Geller DE; Hall JA; Quintana Diez PM
    World J Gastroenterol; 2017 Oct; 23(39):7059-7076. PubMed ID: 29093615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of pancreatic enzyme replacement therapy in patients with a diagnosis of chronic pancreatitis and pancreatic cancer in the US is infrequent and inconsistent.
    Forsmark CE; Tang G; Xu H; Tuft M; Hughes SJ; Yadav D
    Aliment Pharmacol Ther; 2020 May; 51(10):958-967. PubMed ID: 32249970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States.
    Jain T; Sharma P; Giri B; Iyer S; Sethi V; Bava EP; Vaish U; Sahay P; Datta J; Reddy S; Bart Rose J; Khan A; Merchant N; Chari ST; Dudeja V
    HPB (Oxford); 2022 Oct; 24(10):1729-1737. PubMed ID: 35717430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of pancreatic insufficiency in patients with gastrectomy due to cancer or gastric ulcers: a virtual roundtable expert discussion.
    Croagh D; Michalski CW; van Berge Henegouwen MI; Alfieri S
    Expert Rev Gastroenterol Hepatol; 2023 Dec; 17(12):1313-1319. PubMed ID: 38108090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis.
    Domínguez-Muñoz JE; Nieto-Garcia L; López-Díaz J; Lariño-Noia J; Abdulkader I; Iglesias-Garcia J
    BMC Cancer; 2018 May; 18(1):534. PubMed ID: 29728096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding pancreatic exocrine insufficiency and replacement therapy in pancreatic cancer.
    Powell-Brett S; de Liguori Carino N; Roberts K
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt A):539-544. PubMed ID: 32178962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycemic Variability Assessment in Newly Treated Exocrine Pancreatic Insufficiency With Type 1 Diabetes.
    Lewis DM; Shahid A
    J Diabetes Sci Technol; 2024 Mar; 18(2):430-437. PubMed ID: 35787705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exocrine Pancreatic Insufficiency Dosing Guidelines for Pancreatic Enzyme Replacement Therapy Vary Widely Across Disease Types.
    Lewis DM; Rieke JG; Almusaylim K; Kanchibhatla A; Blanchette JE; Lewis C
    Dig Dis Sci; 2024 Feb; 69(2):615-633. PubMed ID: 38117426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study.
    Roberts KJ; Bannister CA; Schrem H
    Pancreatology; 2019 Jan; 19(1):114-121. PubMed ID: 30385188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients.
    Barkin JA; Westermann A; Hoos W; Moravek C; Matrisian L; Wang H; Shemanski L; Barkin JS; Rahib L
    Pancreas; 2019 Jul; 48(6):780-786. PubMed ID: 31210656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.